Dietary supplements represent a huge sector of the consumer market and changes in both intellectual property law and the regulations governing the market entry and advertising of these products is changing.
The new America Invents Act allows anyone to challenge the validity of patents under the inter partes review (IPR) process. In a Sept. 9 webinar, Husch Blackwell Partner Joseph Cwik, who recently won the first pharmaceutical IPR case, will provide an overview of this new process and explain how it is more cost-effective, efficient and successful than the traditional litigation.
Recent complaints to the FDA and FTC regarding lack of enforcement of dietary supplement regulations and marketing claims have spurred both agencies to commence initiatives to step up enforcement. Husch Blackwell Partner Diane Romza-Kutz will discuss what this means for your organization: how to ensure that science supports the claims being made in advertising and marketing materials, and how to respond to the discrepancies in regulation of the same types of claims.
- How to use inter partes review to help get your product to market
- The cheapest and most effective way to invalidate a dietary supplement patent
- How to manage FDA and FTC enforcement actions
Date and Time
Tuesday, Sept. 9, 2014
Noon – 1 p.m. (CDT)
Who Should Attend
Executives in the dietary supplement industry, in-house counsel, and global product development professionals.
The program is complimentary; however, registration is required.
Continuing Education Credit
Continuing Education credit for California, Colorado, Florida, Illinois, Kansas, Missouri, Nebraska, Tennessee, Texas and Utah is pending approval.
Contact Shana Hoy at 816.983.8809.